In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Isoptin Drug Master File in Korea (Isoptin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Isoptin. The MFDS reviews the Isoptin KDMF as part of the drug registration process and uses the information provided in the Isoptin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Isoptin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Isoptin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Isoptin suppliers with KDMF on PharmaCompass.